Raymond E De La Rosa MD
Diabetes, Lipid Metabolism, Parathyroid, Thyroid
Physician
Join to View Full Profile
8383 S Tamiami TrlUnit 115Sarasota, FL 34238
Phone+1 941-841-4206
Fax+1 941-841-4209
Dr. De La Rosa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Raymond de la Rosa is an Endocrinologist in Englewood, FL. A graduate of the University of the Philippines College of Medicine, he completed his residency in Internal Medicine at the Lutheran Medical Center (now NYU - Langone Hospital) and fellowship in Endocrinology, Diabetes and Metabolism at Brown University. Dr. de la Rosa has been in practice for over 24 years.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1995
NYU Grossman School of Medicine/Brooklyn CampusResidency, Internal Medicine, 1990 - 1993
University of the Philippines College of MedicineClass of 1989
Certifications & Licensure
FL State Medical License 2017 - 2027
OR State Medical License 2019 - 2021
KY State Medical License 1994 - 2017
NC State Medical License 2004 - 2013
AR State Medical License 1998 - 2005
OK State Medical License 1998 - 2004
RI State Medical License 1993 - 1996
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Publications & Presentations
PubMed
- 2 citationsEffect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial.Louis B. Chaykin, Anuj Bhargava, Raymond de la Rosa, Carol Wysham, Lone Nørgård Troelsen
Clinical Diabetes. 2019-01-01 - 228 citationsSemaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial.Helena W. Rodbard, Ildiko Lingvay, John C. Reed, Raymond de la Rosa, Ludger Rose
The Journal of Clinical Endocrinology and Metabolism. 2018-06-01 - 171 citationsEffect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.Carol Wysham, Anuj Bhargava, Louis B. Chaykin, Raymond de la Rosa, Yehuda Handelsman
JAMA. 2017-07-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
